Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura
Open Access
- 28 August 2008
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 83 (12), 911-915
- https://doi.org/10.1002/ajh.21281
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- An evaluation of ciclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2006
- An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpuraJournal of Thrombosis and Haemostasis, 2006
- Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpuraBlood, 2006
- A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time‐of‐flight (SELDI‐TOF)‐mass spectrometryJournal of Thrombosis and Haemostasis, 2006
- Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndromeTransfusion, 2005
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsBlood, 2003
- Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary ReviewMayo Clinic Proceedings, 2003
- Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndromeCurrent Opinion in Hematology, 2001
- Cyclosporine-associated thrombotic microangiopathy in renal allograftsKidney International, 1999